AusCann is bringing together leading expertise and operations across all aspects of the medical cannabis value chain, beginning with cultivation and production, through to manufacture and distribution of products.
We are an Australian based company and our aim is to produce and provide high quality, economical and clinically validated cannabis medicines to Australian patients.
We have built a strong team of experts and partners with international connections and the right expertise across all aspects of the medicinal cannabis value chain. By leveraging the intellectual property and capabilities of our global partners we are positioned to become a leading producer and provider of cannabis based medications in Australia.
We are initially targeting medications for neuropathic and chronic pain. Medical cannabis has proven to be an effective treatment in the relief from neuropathic and chronic pain and in Australia alone, this is a $9 billion opportunity. Additionally, medical cannabis has shown to be effective in relieving the symptoms of numerous other conditions including treatment resistant epilepsy, chemotherapy induced nausea and spasticity and spasms in multiple sclerosis patients.
Market Reports /
by Jessica Amir -
6 years ago
26 Apr 2018 - Market Wrap: The ASX closed lower for the first day this week with banks dragging us lower, while a weaker Australian dollar pulled down the miners. Despite that, the…
Market Reports /
by Jessica Amir -
6 years ago
26 Mar 2018 - Market at Midday: Most ASX sectors trade higher, with utilities like AGL (ASX:AGL) gaining 1.8 per cent and health stocks also climbing, with the likes of Healthscope…
Market Reports /
by Jessica Amir -
6 years ago
24 Apr 2018 - Market Wrap:The ASX200 closed above the 5,900 level for the first time in a month, closing back where we were around 1 November last year. Inflation data misses expec…
Market Reports /
by Anna Napoli -
6 years ago
24 Apr 2018 - The Australian share market open has broken above 5,900 for the first time in a month with the ASX200 rising for the second day this week. The market has really shake…
Market Reports /
by Rachael Jones -
7 years ago
28 Mar 2018 - The Australian share market opened lower after some heavy tech-led losses on Wall Street. A2 Milk slipped almost 8 per cent. The Trump administration has signaled tha…
Company News /
by Anna Napoli -
7 years ago
28 Mar 2018 - Medical cannabis company, AusCann (ASX:AC8) has announced its Chilean partner Fundacion Daya has established a scheme which enables immediate access for Chilean pati…
Interviews /
by Jessica Amir -
7 years ago
13 Mar 2018 - AusCann Group Holdings Limited (ASX:AC8) Managing Director, Elaine Darby provides an update on the company's significant progress with its supply chain, industry outr…
Market Reports /
by Jessica Amir -
7 years ago
22 Jan 2018 - Market Wrap: The Australian share market continued its slide from last week, falling below the 6,000 milestone today for the first time since mid December. Financials…
Market Reports /
by Jessica Amir -
7 years ago
17 Jan 2018 - Market Wrap: Australian shares close lower for the second day this week with miners dragging the ASX down. Abacus Property Group's (ASX:ABP) Managing Director, Dr Fr…
Company News /
by Jessica Amir -
7 years ago
07 Dec 2017 - The Office of Drug Control has granted AusCann and its (ASX:AC8) strategic partner, Tasmanian Alkaloids with rights to manufacture and supply medical cannabis in Aust…
Market Reports /
by Jessica Amir -
7 years ago
31 Oct 2017 - Market at Midday: Most of the market rises, shaking off negative leads from Wall Street. Consumer Staples leads charge after Woolworths (ASX:WOW) reported a jump in s…
Interviews /
by Jessica Amir -
7 years ago
18 Sep 2017 - AusCann Group Holdings (ASX:AC8), Managing Director Elaine Darby, talks plan for the year ahead and potential market size in Australia.
Stock Watch /
by -
7 years ago
16 Aug 2017 - Sequoia Wealth Management, CEO Hamish McCathie takes a look at Global Geoscience, Auscann Group and
Airxpanders Inc.
Market Reports /
by Carolyn Herbert -
7 years ago
07 Aug 2017 - AusCann Group Holdings Limited (ASX:AC8) has gone into a trading halt pending the release of a market sensitive announcement by the medicinal cannabis company.
Company News /
by Jessica Amir -
7 years ago
11 Jul 2017 - AusCann Group Holdings’ (ASX:AC8) strategic partner, Tasmanian Alkaloids Pty Ltd, has been granted a medicinal cannabis and a research and development licence from th…
Company Presentations /
by -
7 years ago
14 Jun 2017 - AusCann Group (ASX:AC8) Managing Director Elaine Darby presents at the ASX Spotlight Series in Hong Kong.
Market Reports /
by Carolyn Herbert -
7 years ago
19 May 2017 - Further falls: Aus shares 0.52% lower at noon Computershare Limited (ASX:CPU) addresses media reports in India that it is considering a potential sale of its 50 per …
Market Reports /
by Carolyn Herbert -
7 years ago
17 May 2017 - In the red: Aus shares 0.86% lower at noon. OrotonGroup Limited (ASX:ORL) has provided a trading update to the market saying the Group’s April mid-season sales were …
Market Reports /
by Carolyn Herbert -
7 years ago
05 May 2017 - Aus shares 0.46% lower at noon. Scentre Group Limited (ASX:SCG) has released its first quarter results to the market, saying comparable speciality sales for the year …
